Search
Search Results
-
Assessing Physicians’ Recommendations for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Testing Among Minority Populations in Greater Philadelphia and New York City
Deaths from liver cancer are on the rise and disproportionately affect minority racial/ethnic groups. In this study, we examined associations between...
-
Hepatitis C virus core antigen: A diagnostic and treatment monitoring marker of hepatitis C virus in Indian population
BackgroundThe diagnosis and treatment monitoring of hepatitis C is quite challenging. The screening test, i.e. antibody assay, is unable to detect...
-
High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatment
BackgroundDue to shared modes of transmission, coinfection with hepatitis B virus (HBV) and hepatitis C virus (HCV) is common, and HBV vaccination is...
-
Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
BackgroundOral direct-acting antiviral (DAA) regimens for chronic hepatitis C virus (HCV) infection have greatly improved treatment efficacy, with...
-
Hepatitis C (HCV) prevalence in citizens of the Métis Nation of Ontario
BackgroundHepatitis C virus (HCV) infection is a major global concern, with Indigenous Peoples bearing the highest burden. Previous studies exploring...
-
Reactivation of hepatitis C virus caused by steroid monotherapy for sudden deafness
Hepatitis C virus (HCV) reactivation has been reported to be caused due to several anticancer drugs and immunosuppressive agents; however, HCV...
-
Global Hepatitis C Virus Elimination — Where Are We?
Purpose of ReviewThe study aims to provide an overview of hepatitis C virus (HCV) elimination strategies and actions to show the progression of...
-
Planning, implementing, and evaluating Hepatitis C virus elimination via collaborative community-based care cascade: age–period–cohort model for estimating demand from antecedent anti-HCV survey
BackgroundEstimating the demand for HCV care cascade plays an important role in planning, monitoring, and assessing the performance of introducing a...
-
Dual versus triple therapy in treatment of hepatitis C virus (HCV)
BackgroundThe goal of HCV treatment is eradication of the virus to prevent complications associated with the disease and decrease all-cause...
-
Seroprevalence of hepatitis C virus in **an, China, 2008–2020
BackgroundThe updated estimates of hepatitis C virus (HCV) seroprevalence are critical for develo** strategies to manage or eliminate HCV infection.
...
-
Hepatocellular Carcinoma in the Era of Direct Antiviral Agents Against Hepatitis C Virus
Purpose of ReviewThe hepatitis C virus (HCV) is a major cause of liver-related morbidity and mortality, and a major risk factor of hepatocellular...
-
The Seroprevalence of Hepatitis C Virus (HCV) in Hemodialysis Patients in Oman: A National Cross-Sectional Study
BackgroundHCV infection in hemodialysis units is a significant cause of morbidity and mortality. The risk of HCV infection among dialysis patients is...
-
Unraveling IL-17 and IL-22 role in occult hepatitis C versus chronic hepatitis C virus infection
BackgroundCytokines play a crucial role in regulating the function of the immune system by controlling the production, differentiation, and activity...
-
The care cascade for hepatitis C virus and prognosis of chronic hepatitis C patients treated with antiviral agents in a tertiary hospital
BackgroundSome studies have analyzed the frequency of HCV RNA testing and actual treatment among anti-HCV positive patients in Korea, which has a low...
-
Hepatitis C virus infection in children and adolescents: a management update
Hepatitis C virus infection is an emerging problem for children and adolescents. Chronic HCV infection affects approximately 3.5–5 million children...
-
Hepatitis C virus subtype diversity and transmission clusters characteristics among drug users in Zhuhai, South China
BackgroundHepatitis C virus (HCV) infection poses a major public health challenge globally, especially among injecting drug users. China has the...
-
Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR
Hepatitis C virus infection is characterized by chronic liver inflammation and fibrogenesis, leading to end-stage liver failure and hepatocellular...
-
Hepatitis C in Haftanstalten
BackgroundDespite general advances in the treatment of people with hepatitis C in Germany, it is unclear to what extent this also applies to specific...
-
Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study
Background and ObjectivesDirect-acting antivirals (DAAs) offer a high rate of hepatitis C virus (HCV) eradication. However, concerns on the risk of...
-
Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China
IntroductionA pan-genotypic and effective treatment regimen for patients with chronic hepatitis C virus (HCV) infection remains an unmet medical need...
